Key facts
- AberActives’s last known valuation is $3.5M (Nov 2025).
- It has raised $1.3M; the latest was Seed Round ($1.2M) in Nov 2025.
- Notable investors include Emergys Bretagne, Finistere Angels, Station Biologique de Roscoff.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for AberActives
- ·The full record, as it builds
Funding rounds
No funding rounds for AberActives are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AberActives
Provider of marine-biotech services designed to produce algal bio-actives for cosmetic and nutraceutical applications. The company uses proprietary bacterial enzymes to break down algal polysaccharides, enabling ingredient manufacturers in the cosmetics and nutraceuticals industries to obtain bioactive compounds from seaweed through a sustainable low-energy process.
- Sector
- Healthcare
- HQ
- Roscoff, France
- Founded
- 2021
- Employees
- 8
- Website
- aberactives.com/
- Ownership
- Privately Held (backing)
AberActives doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AberActives shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AberActives in its N-PORT filings yet. We sweep new filings monthly.